The use ofin vitrotechnologies coupled with high resolution accurate mass LC‐MS for studying drug metabolism in equine drug surveillance

Authors:

Abstract
The detection of drug abuse in horseracing often requires knowledge of drug metabolism, especially if urine is the matrix of choice. In this study, equine liver/lung microsomes/S9 tissue fractions were used to study the phase I metabolism of eight drugs of relevance to equine drug surveillance (acepromazine, azaperone, celecoxib, fentanyl, fluphenazine, mepivacaine, methylphenidate and tripelennamine).In vitrosamples were analyzed qualitatively alongside samples originating fromin vivoadministrations using LC‐MS on a high resolution accurate mass Thermo Orbitrap Discovery instrument and by LC‐MS/MS on an Applied Biosystems Sciex 5500 Q Trap.Using high resolution accurate mass full‐scan analysis on the Orbitrap, thein vitrosystems were found to generate at least the two most abundant phase I metabolites observedin vitrofor all eight drugs studied. In the majority of cases,in vitroexperiments were also able to generate the minorin vivometabolites and sometimes metabolites that were only observedin vitro. More detailed analyses of fentanyl incubates using LC‐MS/MS showed that it was possible to generate good quality spectra from the metabolites generatedin vitro. These data support the suggestion of usingin vitroincubates as metabolite reference material in place ofin vivopost‐administration samples in accordance with new qualitative identification guidelines in the 2009 International Laboratory Accreditation Cooperation‐G7 (ILAC‐G7) document.In summary, thein vitroandin vivophase I metabolism results reported herein compare well and demonstrate the potential ofin vitrostudies to compliment, refine and reduce the existing equinein vivoparadigm. Copyright © 2010 John Wiley & Sons, Ltd.

This publication has 18 references indexed in Scilit: